Some school districts, including MSCS, have what's called a self-funded health plan. That means the employer pays for ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The research, spearheaded by Dr Manohar KN, Chairman of Disha India; Vijay Kumar K, Honorary Secretary of KRSSDI; and Dr ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

It is necessary to revolutionise diabetes care beyond just medical prescriptions from doctors but also mental health care ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

Impedance cardiography provides clinicians and patients with deeper insights than a standard EKG, enhancing medication ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly proposed a plan to ensure 340B entities pay no more than the ceiling price by providing them with cash directly on ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

By Albert Allotey Accra, Nov. 15, GNA – Some Civil Society Organisations (CSOs) have called for the urgent need to for a comprehensive approach to managing diabetes, ...